For this reason, SDF-1α-CXCR4 is of considerable interest in ischaemic cardiomyopathy and several studies have demonstrated that prolonged SDF-1α delivery after experimental MI can improve cardiac function [[15], [16], [17], [18], [19]]. Here, CXCL12 is linked to myocardial infarction.